THE COMPLETE SEQUENCE (1-330) TOGETHER WITH THE HIS-TAG WAS USED IN CRYSTALLIZATION. THE PROTEIN ...THE COMPLETE SEQUENCE (1-330) TOGETHER WITH THE HIS-TAG WAS USED IN CRYSTALLIZATION. THE PROTEIN WAS INCUBATED WITH CHYMOTRYPSIN RIGHT BEFORE CRYSTALLIZATION, AND SUBJECTED TO THE LIMITED PROTEOLYSIS. THE COMPLETE LENGTH OF THE CRYSTALLIZED SEQUENCE IS UNKNOWN. THE REPORTED SEQUENCE IS THE ONE OBSERVED IN THE EXPERIMENT.
-
実験情報
-
実験
実験
手法: X線回折 / 使用した結晶の数: 1
-
試料調製
結晶
マシュー密度: 1.87 Å3/Da / 溶媒含有率: 34.06 %
結晶化
温度: 289 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7.5 詳細: 0.2 ul of 9 mg/ml protein in 20 mM HEPES pH 7.5, 150 mM NaCl, 10% Glycerol, 0.1% Sodium Azide and 0.5 mM TCEP were mixed with 0.2 ul of the MCSG-II condition #27 (0.2 M Ammomium Acetate, 0.1 ...詳細: 0.2 ul of 9 mg/ml protein in 20 mM HEPES pH 7.5, 150 mM NaCl, 10% Glycerol, 0.1% Sodium Azide and 0.5 mM TCEP were mixed with 0.2 ul of the MCSG-II condition #27 (0.2 M Ammomium Acetate, 0.1 M HEPES:NaOH pH 7.5, 25% (w/v) PEG 3350) and equilibrated against 1.5 M NaCl solution in QIAGEN EasyXtal 15-Well Tool plate. Before crystallization protein was incubated with 1/50 v/v of 2 mg/ml chymotrypsin solution at 289 K for 3 hours, VAPOR DIFFUSION, SITTING DROP